These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 6809445

  • 1. Neuroendocrine abnormalities in affective disorders.
    Extein I, Pottash AL, Gold MS.
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [Abstract] [Full Text] [Related]

  • 2. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD.
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [Abstract] [Full Text] [Related]

  • 3. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD.
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [Abstract] [Full Text] [Related]

  • 4. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H, Kaufman L, De Weert D, Cornet C, Raets I.
    Acta Psychiatr Belg; 1984 Jan; 84(3):228-34. PubMed ID: 6435395
    [Abstract] [Full Text] [Related]

  • 5. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Weissenburger JE, Fulton CL, Fairchild CJ, Roffwarg HP.
    Biol Psychiatry; 1997 May 01; 41(9):915-28. PubMed ID: 9110097
    [Abstract] [Full Text] [Related]

  • 6. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL, Newbury N.
    J Clin Psychiatry; 1985 Jun 01; 46(6):217-21. PubMed ID: 3922959
    [Abstract] [Full Text] [Related]

  • 7. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
    Cervera S.
    Rev Esp Fisiol; 1989 Jun 01; 45 Suppl():279-87. PubMed ID: 2518335
    [Abstract] [Full Text] [Related]

  • 8. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H, Moron P.
    Encephale; 1983 Jun 01; 9(1):1-22. PubMed ID: 6135596
    [Abstract] [Full Text] [Related]

  • 9. Clinical correlates of the TRH infusion test in primary depression.
    Kirstein L, Gold MS, Extein I, Martin D, Pottash AL.
    J Clin Psychiatry; 1982 May 01; 43(5):191-4. PubMed ID: 6804446
    [Abstract] [Full Text] [Related]

  • 10. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM, Mendlewicz J.
    Biol Psychiatry; 1996 Sep 01; 40(5):412-8. PubMed ID: 8874844
    [Abstract] [Full Text] [Related]

  • 11. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug 01; 24(4):203-6, 251. PubMed ID: 1954790
    [Abstract] [Full Text] [Related]

  • 12. Thyrotropin-releasing hormone test and male unipolar depression.
    Kirstein L, Gold MS, Pottash AL, Extein I.
    Biol Psychiatry; 1981 Sep 01; 16(9):819-24. PubMed ID: 6794655
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and subtyping of depressive disorders by quantitative electroencephalography: III. Discriminating unipolar from bipolar depression.
    Lieber AL, Newbury ND.
    Hillside J Clin Psychiatry; 1988 Sep 01; 10(2):165-72. PubMed ID: 3147236
    [Abstract] [Full Text] [Related]

  • 14. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E, Kartalci S, Tutus A, Turan T, Sofuoglu S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 01; 28(2):303-9. PubMed ID: 14751427
    [Abstract] [Full Text] [Related]

  • 15. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT, Marciniak R.
    Pharmacopsychiatry; 1988 May 01; 21(3):131-5. PubMed ID: 3136464
    [Abstract] [Full Text] [Related]

  • 16. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ, Schlesser MA, Roffwarg HP, Giles DE, Orsulak PJ, Fairchild C.
    J Clin Psychiatry; 1983 Aug 01; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [Abstract] [Full Text] [Related]

  • 17. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD, Sullivan AC, Byrnes SM.
    Am J Psychiatry; 1982 Mar 01; 139(3):282-6. PubMed ID: 6800269
    [Abstract] [Full Text] [Related]

  • 18. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G.
    J Affect Disord; 2007 Jun 01; 100(1-3):65-73. PubMed ID: 17098292
    [Abstract] [Full Text] [Related]

  • 19. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A, Taneli B, Sivrioğlu Y.
    Turk Psikiyatri Derg; 2003 Jun 01; 14(2):116-24. PubMed ID: 12844278
    [Abstract] [Full Text] [Related]

  • 20. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI, Halaris A, Baxter L, Schwarcz G, Thompson M, Hurwicz ML, Hill M, Young M, Daugherty K, Clemens A.
    Psychopharmacol Bull; 1985 Jun 01; 21(1):77-80. PubMed ID: 3920706
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.